Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Zepbound (tirzepatide) and Wegovy (semaglutide) both activate hunger-suppressing pathways in the brain, but they work through different receptor targets. Clinical trials show tirzepatide produces slightly greater average weight loss, though individual results vary based on genetics, metabolism, and lifestyle. Understanding how each medication functions can help you make an informed choice about weight loss therapy.
How Tirzepatide and Semaglutide Work Differently
Semaglutide (Wegovy) activates one main receptor type called GLP-1, which slows stomach emptying and signals fullness to your brain. Tirzepatide (Zepbound) activates two receptor types: GLP-1 and GIP, creating a dual-action effect that suppresses hunger more powerfully in many patients. This structural difference explains why some people experience stronger appetite reduction on tirzepatide, while others respond equally well to semaglutide alone.
Both medications belong to the GLP-1 class and share similar side effects like nausea and constipation, especially during dose increases. The dual-receptor action of tirzepatide may provide additional metabolic benefits, including improved insulin sensitivity, though both compounds improve blood sugar control. Your individual genetic makeup influences how effectively each medication works for your body—a factor PlexusDx explores through the Precision Peptide Genetic Test.
Clinical Trial Results: Weight Loss Comparisons
In the SUSTAIN trials, semaglutide achieved average weight loss of 10–15% of body weight over 68 weeks at the highest dose. Tirzepatide demonstrated greater weight reduction in the SURMOUNT trials, with patients losing 20–22% of body weight at maximum dose over comparable timeframes. While tirzepatide's average results appear superior, both medications show wide individual variation—some patients lose dramatically more on semaglutide, depending on their metabolism and adherence.
Real-world data from compounded GLP-1 therapy shows that dose tolerance, consistency, and lifestyle changes matter as much as the medication itself. Many patients achieve significant results on lower doses when combined with dietary changes and physical activity. PlexusDx helps you start at an affordable tier and adjust as your body responds, with the pricing structure staying flat regardless of dose escalation.
Cost and Accessibility: Compounded Options vs Brand Names
Brand-name Zepbound and Wegovy often cost $900–$1,400 monthly through insurance or cash pay, with many plans covering only partial amounts or imposing strict criteria. PlexusDx compounded tirzepatide injection starts at $249 per month from licensed 503A compounding pharmacies, and compounded semaglutide injection begins at $149 monthly—removing the barrier of insurance approval delays. Both PlexusDx formulations are HSA and FSA eligible, giving you tax-advantaged ways to pay for therapy.
The compounding advantage extends beyond price: no membership fees, no insurance wrestling, and availability in all 50 states. Your dose may need to go up as your body adapts, but your PlexusDx monthly price stays flat across commitment tiers—whether you start at microdose or standard strength. This transparent pricing model lets you focus on results instead of calculating costs at each tier increase.
Genetics, Response Patterns, and Personalized Therapy Selection
Your genes influence how strongly your GLP-1 and GIP receptors respond to medication, which helps explain why two people on identical doses experience vastly different hunger suppression and weight loss. The Precision Peptide Genetic Test maps 14 pathways across 49 peptides and identifies key variants like GLP1R rs6923761 and GIPR rs1800437 that predict your metabolic response pattern. This genetic insight allows PlexusDx to guide you toward tirzepatide, semaglutide, or even dual-compound options based on your biology rather than trial and error.
For patients with specific genetic predispositions—such as reduced GLP-1 receptor sensitivity—tirzepatide's dual-receptor action may overcome that limitation more effectively. Conversely, patients with strong GLP-1 receptor expression may achieve excellent results on semaglutide alone at a lower monthly cost. Adding the genetic test after your first month of treatment helps refine your long-term therapy choice and optimizes your path to sustainable weight loss.
Which Medication Should You Choose?
If cost is your primary concern and you tolerate GLP-1 monotherapy well, compounded semaglutide injection starting at $149 monthly offers exceptional value with proven efficacy. If you want maximum average weight loss potential and have budget flexibility, tirzepatide's dual action justifies its higher starting price of $249 monthly for many patients. Your medical history, prior medication responses, and metabolic markers should inform this decision alongside your personal preferences and financial situation.
PlexusDx simplifies the decision-making process by offering both medications at transparent, dose-flat pricing, plus the option to add genetic testing for deeper personalization. Starting with a consultation allows you to discuss your goals, prior GLP-1 experience, and any side effect concerns with a healthcare provider before committing to either compound. Many patients discover their optimal fit through professional guidance rather than assumptions about which medication works 'better'—because better is always individual.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Zepbound better than Wegovy for weight loss?
Clinical trials show tirzepatide (Zepbound) produces slightly greater average weight loss than semaglutide (Wegovy), but individual results vary significantly based on genetics and metabolism. Neither medication is universally 'better'—the right choice depends on your body's receptor sensitivity, tolerance to side effects, and financial circumstances. PlexusDx offers both as compounded options, letting you choose based on evidence and personal factors.
What is the difference between tirzepatide and semaglutide mechanisms?
Semaglutide activates the GLP-1 receptor alone, while tirzepatide activates both GLP-1 and GIP receptors. This dual action gives tirzepatide stronger appetite suppression in many patients and additional metabolic benefits like enhanced insulin sensitivity. Your genetic variants in these receptor genes influence how powerfully each medication works for your specific body.
How much does PlexusDx tirzepatide cost compared to brand Zepbound?
PlexusDx compounded tirzepatide injection starts at $249 monthly, compared to $900–$1,400 for brand-name Zepbound. Your dose may increase over time, but your PlexusDx price remains flat—no hidden costs or tier-based jumps. The medication comes from licensed 503A compounding pharmacies and is available in all 50 states without insurance.
Are compounded tirzepatide and semaglutide safe?
Yes. PlexusDx sources all compounded GLP-1 medications from licensed 503A compounding pharmacies, which follow strict FDA manufacturing and quality standards. Both semaglutide and tirzepatide have extensive clinical safety data, with side effects typically mild and manageable—nausea, constipation, and appetite loss are most common and usually improve over time.
How does the Precision Peptide Genetic Test help me choose between tirzepatide and semaglutide?
The Precision Peptide Genetic Test ($99 after your first month) identifies variants in your GLP1R and GIPR genes and maps 14 metabolic pathways across 49 peptides. If your results show reduced GLP-1 receptor sensitivity, tirzepatide's dual action may work better; if you have strong GLP-1 expression, semaglutide alone may suffice. This personalized insight removes guesswork from your medication selection.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic for Weight Loss? Understanding Its Role and Effects
Understanding the Side Effects of Ozempic: What to Expect and How to Manage Them